| 價(jià)格 | 詢價(jià) | ||
| 包裝 | 1支 | 5支 | 10支 |
| 最小起訂量 | 1支 |
| 發(fā)貨地 | 北京 |
| 更新日期 | 2026-06-30 |
| 中文名稱:CD30試劑盒 | 英文名稱:CD30 ELISA Kit |
| 品牌: 百普賽斯 | 產(chǎn)地: 北京 |
| 保存條件: -20°C to -70°C | 純度規(guī)格: 99.9% |
| 產(chǎn)品類別: 試劑盒 | |
| 檢測(cè)方法: 試劑盒 | 種屬反應(yīng)性: 試劑盒 |
| 數(shù)量: 999 | 保質(zhì)期: 12個(gè)月 |
| 貨號(hào): EP-135 | 是否進(jìn)口: 否 |
| 適應(yīng)物種: Human |

背景(Background)
CD30 belongs to the tumor necrosis factor receptor (TNFR) superfamily, and the physiological functions of CD30 are in addition to the transmission of synergistic stimulation signals. CD30 ligand (CD30L) belongs to the tumor necrosis factor (TNF) superfamily, and CD30L is present in activated T cells, quiescent B cells, granulocytes, thymic medullary cells, and various leukemia cells. After crosslinking CD30 and CD30L, diverse physiological function signaling is led by TNFR correlation factors (TRAF), including TRAF1, 2, 3, 5. CD30 was originally found in Hodgkin's lymphoma and Reed Sternberg (RS) cells, and is now known to be expressed on the surface of some normal lymphocytes, virally infected lymphocytes, lymphocytes of lymphogenetic origin, and activated T cell subsets that produce Th2 cytokines.
原理(Assay Principles)
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new CD30 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human CD30 to immobilized human CD30 Ligand in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated CD30 protein, a human CD30 Ligand protein, an anti-CD30 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.
Your experiment will include 4 simple steps:
a) Coat the plate with human CD30 Ligand.
b) Add your molecule of interest to the tests.
c) Add human CD30-Biotin to bind the coated CD30 Ligand.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
e) Finally, the half maximal inhibitory concentration (IC50) of your compound to CD30 Ligand: CD30 binding will be determined by comparing OD readings among different experimental groups.
應(yīng)用說明(Application)
This kit is developed for screening for inhibitors of human CD30 binding to human CD30L.
It is for research use only.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
存儲(chǔ)(Storage)
Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

| 成立日期 | 2010-07-22 (17年) | 注冊(cè)資本 | 8000萬人民幣 |
| 員工人數(shù) | 500人以上 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 | 經(jīng)營模式 | 工廠,試劑 |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| ¥1280 |
VIP1年
|
上海雙贏生物科技有限公司
|
2026-08-05 | |
| ¥2100 |
VIP1年
|
上海聯(lián)邁生物工程有限公司
|
2026-08-04 | |
| ¥1280 |
VIP1年
|
上海潤裕生物科技有限公司
|
2026-08-05 | |
| ¥1200 |
VIP1年
|
上海研生實(shí)業(yè)有限公司
|
2026-08-05 | |
| ¥1200 |
上海嘉定區(qū)澄瀏公路52號(hào)
|
2025-11-06 |